Additional file 3: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

Significant estimates on a level of p < .05 are printed bold. A = COPD patients without Alpha-1-antitrypsin deficiency (AATD), B1 = COPD patients with AATD and augmentation therapy (AT), B2 = COPD patients with AATD but without AT. EQ-5D-3 L values are given after multiplication by 100. (DOC 47 kb)